FGFR as a Predictive Marker for Targeted Therapy in Gastrointestinal Malignancies: A Systematic Review
{{output}}
Background: Gastrointestinal (GI) cancers constitute approximately 25% of cancers worldwide. The fibroblast growth factor receptor (FGFR) family is a promising target for immunotherapy aiming to enhance survival rates. FGFR alter... ...
